Michael A. Fischer, MD, MS

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Michael Fischer, MD, MS is Chief of the Section of General Internal Medicine at Boston Medical Center/Chobanian and Avedisian School of Medicine. He is a primary care physician and health services researcher with expertise in developing and evaluating interventions to increase the use of evidence-based medical practices.

Dr. Fischer began his career at Brigham and Women’s Hospital, conducting research evaluating medication adherence; the appropriate use of prescription drugs; dissemination and implementation of evidence-based practices; prescription drug reimbursement policy; and the impact of electronic prescribing. He is the Director of the National Resource Center for Academic Detailing (www.NaRCAD.org), an initiative supported by the Agency for Health Care Research and Quality and the Centers for Disease Control and Prevention to assist organizations implementing interventions to improve health care quality and patient outcomes.

Publications

  • Published 11/17/2025

    Schulson LB, Fischer MA, Streed CG. A Dangerous Retreat: Defunding AHRQ and the Threat to Diagnostic Safety. J Gen Intern Med. 2026 Apr; 41(5):1410-1412. PMID: 41249651.

    Read at: PubMed

  • Published 10/9/2025

    Morgan-Barsamian AR, El Ibrahimi S, Hendricks MA, Blalock KL, Stack E, Wyss R, Hatch BA, Sánchez V, Fischer MA. Impact of a Multi-Factorial Primary Care Intervention on Opioid Use Disorder Treatment and Overdose Outcomes. J Prim Care Community Health. 2025; 16:21501319251375393. PMID: 41065116.

    Read at: PubMed

  • Published 8/18/2025

    Miyawaki A, Ladines-Lim JB, Sato D, Kitajima K, Linder JA, Fischer MA, Chua KP, Tsugawa Y. Association of patient, physician and visit characteristics with inappropriate antibiotic prescribing in Japanese primary care: a cross-sectional study. BMJ Public Health. 2025; 3(2):e002364. PMID: 40842720.

    Read at: PubMed

  • Published 7/23/2025

    Brown T, Guzman A, Lee JY, Fischer MA, Friedberg MW, Linder JA. Clinicians' Reasons for Non-Visit-Based, No-Infectious-Diagnosis-Documented Antibiotic Prescribing: A Sequential Mixed-Methods Study. Antibiotics (Basel). 2025 Jul 23; 14(8). PMID: 40867935.

    Read at: PubMed

  • Published 8/16/2024

    Chua KP, Fischer MA, Rahman M, Linder JA. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data. Clin Infect Dis. 2024 Aug 16; 79(2):312-320. PMID: 38648159.

    Read at: PubMed

Other Positions

  • Section Chief, Medicine
    Boston University Chobanian & Avedisian School of Medicine

Education

  • Yale University School of Medicine, MD
  • Harvard School of Public Health, MS
  • Harvard College, AB